Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation.
Saved in:
| Title: | Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation. |
|---|---|
| Authors: | Hammadeh BM; Al-Balqa' Applied University, Salt, Jordan. Barahammadeh2005@gmail.com., Sameer S; Jordan University of Science and Technology, Irbid, Jordan., Alnajjar M; Jordan University of Science and Technology, Irbid, Jordan., Abu-Issa I; Jordan University of Science and Technology, Irbid, Jordan., Alhallaq MS; Mansoura University, Mansoura, Egypt., Ghazi M; Jordan University of Science and Technology, Irbid, Jordan., Badr A; Department of General Surgery, Hamad Medical Corporation, Doha, Qatar., Shawawrah M; Neurology Division, Department of Medicine, Queen's University, Kingston, ON, Canada. |
| Source: | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2026 Jul 03; Vol. 47 (8). Date of Electronic Publication: 2026 Jul 03. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis; Review |
| Journal Info: | Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
